Taken together these results indicate that FGF21 plays a vital role in multiple metabolic syndromes and has the potential to become an influential therapeutic option to alleviate the symptoms of NAFLD. Here, FGF21 is linked to metabolic dysfunction-associated steatotic liver disease.